𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P03-182 A 16-week, multicentre, randomized, open-label study assessing effects of aripiprazole versus other atypicals for schizophrenia patients with metabolic syndrome

✍ Scribed by Day-Poulsen, H.; Thomas, P.; Loze, J.-Y.; Fortan, L.; Kerselaers, W.; Owen, R.


Book ID
123579982
Publisher
Elsevier Science
Year
2009
Tongue
French
Weight
49 KB
Volume
24
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.